Publication
Number of items: 6.
28 October 2022
  • Therapeutic use of calpeptin in COVID-19 infection. (2022) Jameel Inal, Ainura Paizuldaeva and Esmeralda Terziu
    • 9 May 2017
  • Diabetes confers in vitro calcific potential on serum which associates with in-vivo vascular calcification. (2017) Ashish Patidar, Dhruv Singh, Shori Thakur, Peter Winocour, Kenneth Farrington and Anwar Baydoun
    • March 2013
  • Human uraemic serum displays calcific potential in vitro that increases with advancing chronic kidney disease. (2013) Ashish Patidar, Dhruv Singh, Peter Winocour, Ken Farrington and A. R. Baydoun
    • 2000
  • The gain-of-function G389R variant of the β1-adrenoceptor does not influence blood pressure or heart rate response to β-blockade in hypertensive subjects. (2000) K.M. O'Shaughnessy, B. Fu, Claire Dickerson, D. Thurston and M.J. Brown
    • 1994
  • Effects of physiological increments in human alpha-atrial natriuretic peptide and human brain natriuretic peptide in normal male subjects. (1994) B.M. Cheung, Claire Dickerson, M.J. Ashby, M.J. Brown and J. Brown
    • 1990
  • A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma : comparison of levels in patients with essential hypertension and normotensive control subjects. (1990) A. Davenport, M.J. Ashby, P. Easton, S. Ella, J. Bedford, Claire Dickerson, D.J. Nunez, S.J. Capper and M.J. Brown